South Korea
· Delayed Price · Currency is KRW Englewood Lab Statistics
Total Valuation
Englewood Lab has a market cap or net worth of KRW 136.69 billion. The enterprise value is 136.77 billion.
| Market Cap | 136.69B |
| Enterprise Value | 136.77B |
Important Dates
The next estimated earnings date is Tuesday, January 21, 2025.
| Earnings Date | Jan 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Englewood Lab has 19.87 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 19.87M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 5.08% |
| Owned by Institutions (%) | 2.48% |
| Float | 9.11M |
Valuation Ratios
The trailing PE ratio is 9.16.
| PE Ratio | 9.16 |
| Forward PE | n/a |
| PS Ratio | 0.69 |
| PB Ratio | 1.08 |
| P/TBV Ratio | 1.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.99, with an EV/FCF ratio of -269.29.
| EV / Earnings | 9.17 |
| EV / Sales | 0.69 |
| EV / EBITDA | 4.99 |
| EV / EBIT | 5.95 |
| EV / FCF | -269.29 |
Financial Position
The company has a current ratio of 3.06, with a Debt / Equity ratio of 0.24.
| Current Ratio | 3.06 |
| Quick Ratio | 2.09 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 1.11 |
| Debt / FCF | -60.01 |
| Interest Coverage | 27.97 |
Financial Efficiency
Return on equity (ROE) is 12.32% and return on invested capital (ROIC) is 10.08%.
| Return on Equity (ROE) | 12.32% |
| Return on Assets (ROA) | 8.32% |
| Return on Capital (ROIC) | 10.08% |
| Revenue Per Employee | 1.11B |
| Profits Per Employee | 83.79M |
| Employee Count | 178 |
| Asset Turnover | 1.14 |
| Inventory Turnover | 3.81 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -47.52% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -47.52% |
| 50-Day Moving Average | 8,957.00 |
| 200-Day Moving Average | 14,680.25 |
| Relative Strength Index (RSI) | 37.57 |
| Average Volume (20 Days) | 203,931 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Englewood Lab had revenue of KRW 197.00 billion and earned 14.91 billion in profits. Earnings per share was 750.69.
| Revenue | 197.00B |
| Gross Profit | 42.96B |
| Operating Income | 23.00B |
| Pretax Income | 22.03B |
| Net Income | 14.91B |
| EBITDA | 27.39B |
| EBIT | 23.00B |
| Earnings Per Share (EPS) | 750.69 |
Balance Sheet
The company has 30.40 billion in cash and 30.48 billion in debt, giving a net cash position of -83.70 million or -4.21 per share.
| Cash & Cash Equivalents | 30.40B |
| Total Debt | 30.48B |
| Net Cash | -83.70M |
| Net Cash Per Share | -4.21 |
| Equity (Book Value) | 126.56B |
| Book Value Per Share | 6,369.99 |
| Working Capital | 88.97B |
Cash Flow
In the last 12 months, operating cash flow was 4.77 billion and capital expenditures -5.28 billion, giving a free cash flow of -507.91 million.
| Operating Cash Flow | 4.77B |
| Capital Expenditures | -5.28B |
| Free Cash Flow | -507.91M |
| FCF Per Share | -25.56 |
Margins
Gross margin is 21.81%, with operating and profit margins of 11.68% and 7.57%.
| Gross Margin | 21.81% |
| Operating Margin | 11.68% |
| Pretax Margin | 11.18% |
| Profit Margin | 7.57% |
| EBITDA Margin | 13.90% |
| EBIT Margin | 11.68% |
| FCF Margin | n/a |
Dividends & Yields
Englewood Lab does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 13.18% |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 10.91% |
| FCF Yield | -0.37% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Englewood Lab has an Altman Z-Score of 5.87.
| Altman Z-Score | 5.87 |
| Piotroski F-Score | n/a |